Holiday Sale — Get 40% off Vantage for yourself or as a gift

Published 2 days ago • loading... • Updated 2 days ago

GC Biopharma Secures IND Approval for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea

Summary by Charleston Gazette-Mail

Phase 2 IND submission targeted for the second half of 2026

62 Articles

62 Articles

Bennington Banner

PR Newswire

Charleston Gazette-Mail

Watauga Democrat

Rockdale Citizen & Newton Citizen

WBOC 16

Local 3 News

Floyd Chronicle & Times

ashepostandtimes.com

TBNweekly

Henry Herald

cbs19news.com

Brattleboro Reformer

Jackson Progress-Argus

The Sanford Herald

The Berkshire Eagle

Glens Falls Post-Star

Madison Courier

Record Argus - Serving Greenville, PA since 1848

Mt. Airy News

Islander News

blackbeltnewsnetwork.com

The Progress

waynecountynews.com

The Coal Valley News

Bryan Times

williamsondailynews.com

The Daily News

The Logan Banner

newsontheneck.com

romesentinel.com

stonecountyenterprise.com

Suncoast News

The Times-News

The AI Journal

Woonsocket Call

therogersvillereview.com

WDEL 101.7FM

The Daily News - Jacksonville, NC

LoudounTimes.com

Williamson Herald

coastaltvnews.com

Chatham Star Tribune

Herald Chronicle

blockislandtimes.com

The Elkin Tribune

Saint Albans Messenger

News of Orange

The Caswell Messenger

Florida Courier

daily-tribune.com

thesussexsurrydispatch.com

Rappahannock News

thesentinel.com

Observer News Enterprise

Yadkin Ripple

miltonindependent.com

Daytona Times

SRI News

Lincoln Times News

delmarvasportsnetwork.com

dailytimesleader.com

+61 Reposted by 61 other sources

GC Biopharma Secures IND Approval for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea

Phase 2 IND submission targeted for the second half of 2026

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources62

Leaning Left7Leaning Right5Center22Last Updated2 days agoBias Distribution

65% Center

Bias Distribution

65% of the sources are Center

65% Center

+2

+17

Untracked bias

+19

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States 2 days ago on Tuesday, December 23, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics